メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
内分泌・代謝・糖尿病内科学
藤田医科大学
医学部
概要
フィンガープリント
ネットワーク
プロファイル
(8)
研究成果
(52)
フィンガープリント
内分泌・代謝・糖尿病内科学が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Osteoporosis
19%
Asia-Pacific Region
19%
Comorbid
19%
Glucagon Stimulation Test
19%
Asia-Pacific
19%
Phosphate Transporter
19%
Primary Aldosteronism
19%
Type I Diabetes
19%
Executive Summary
19%
Interleukin-6
19%
Ectopic Calcification
19%
Calcium-phosphorus Metabolism
19%
Extraskeletal Calcification
19%
Fiber Composition
19%
Multifactorial Intervention
19%
Pregnant Japanese Women
19%
Threatened Preterm Birth
19%
Liaison Service
19%
Fracture Epidemiology
19%
Fracture Liaison
19%
Fracture Management
19%
Osteoporosis Liaison Service
19%
Screening Diagnosis
19%
Management Services
19%
Antidiabetic Drugs
19%
Plasma Vascular Endothelial Growth Factor
19%
Autoimmune Thyroiditis
19%
Prostaglandins F
19%
Simultaneous Measurement
19%
IP-10
19%
Medication-related
19%
Osteoporosis Prevention
19%
Glucocorticoid-induced Osteoporosis
19%
Secondary Osteoporosis
19%
Subclinical Hypothyroidism
19%
Pituitary Gigantism
19%
Randomized Phase II Trial
19%
Collaborative Initiatives
19%
Innovative Initiatives
19%
Emerging Challenges
19%
Bone Metabolism
19%
Recent Advances
19%
Pharmacological Management
19%
Hypertensive Patients
19%
Osteoblast Cells
19%
High-sensitivity Assay
19%
Protein Kinase
19%
Atrial Fibrillation
19%
Standard of Care
19%
Clinical Standards
19%
KKAy Mice
19%
Hashimoto's Thyroiditis
16%
Graves' Disease
16%
Hormone Concentration
16%
Bone Resorption
14%
Bisphosphonates
14%
KKAy
14%
Vascular Smooth muscle Cells
13%
Hypo
13%
Thiazolidinediones
13%
T Level
12%
Plasma Endothelin
9%
Biochemical Control
9%
Bone Formation
9%
Cardiovascular Events
8%
Serum 25(OH)D Levels
7%
Side Dishes
7%
68Ga-DOTATOC PET
6%
Hypothyroid
6%
Disease Specificity
6%
Pi Deprivation
6%
In Vivo Function
6%
Bone Development
6%
Extracellular Milieu
6%
Long Bone
6%
Overt Proteinuria
6%
Hypophosphatemia
6%
Transgenic Mouse Model
6%
Soft Tissue
6%
Bone Mass
6%
Bone Structure
6%
Bone Biomaterials
6%
FRAX®
6%
Microstructure Properties
6%
Material Properties
6%
Diabetes Drugs
6%
Prediction Algorithms
6%
Fracture Prediction
6%
Bone Microarchitecture
6%
Marker Prediction
6%
Adults with Diabetes
6%
Bone Status
6%
Incretin Enhancer
6%
Incretin Mimetics
6%
Metabolic Control
6%
Fragility Fracture Risk
6%
Incretin
6%
Jun Kinase
5%
Adipose Tissue Weight
5%
Phorbol 12-myristate 13-acetate
5%
Pharmacology, Toxicology and Pharmaceutical Science
Fragility Fracture
70%
Non Insulin Dependent Diabetes Mellitus
70%
Bone Fragility
43%
Glucocorticoid
39%
Biochemical Marker
29%
Chronic Kidney Failure
26%
Spine Fracture
24%
Loop Diuretic Agent
23%
Cardiovascular Disease
23%
Protein Kinase C
22%
Troponin T
21%
Hemoglobin A1c
21%
Secondary Osteoporosis
19%
Disease
19%
Gastric Inhibitory Polypeptide
19%
Disease Course
19%
Vasculotropin
19%
Chronic Disease
19%
Selective Serotonin Reuptake Inhibitor
19%
Interleukin 6
19%
Prostaglandin D2
19%
Premature Labor
19%
PPAR Agonist
19%
Incretin
19%
Prostaglandin F
19%
Proton Pump Inhibitor
19%
Autoimmune Thyroiditis
19%
Sex Hormone
19%
Phosphate Transporter
19%
Fatty Acid Binding Protein
19%
Injury
19%
ECG Abnormality
19%
Anticonvulsive Agent
19%
Endothelin 1
19%
Randomized Controlled Trial
19%
Gigantism
19%
Acromegaly
19%
Thyrotropin
19%
Subclinical Hypothyroidism
19%
Fibrinogen
19%
Risedronic Acid
19%
KK-Ay Mouse
19%
Sarcoidosis
19%
Microbiome
19%
Interstitial Lung Disease
19%
Diabetes Mellitus
18%
Bisphosphonic Acid Derivative
17%
Fibrosing Alveolitis
16%
Graves Disease
13%
Hashimoto Disease
13%
Thiazolidinedione
13%
Low Density Lipoprotein Cholesterol
11%
All Cause Mortality
11%
Creatinine
11%
Disease Duration
9%
Hip Fracture
9%
Brain Natriuretic Peptide
8%
Coronary Artery Disease
7%
Heart Infarction
7%
Cystatin C
7%
Dipeptidyl Peptidase IV Inhibitor
6%
Dysbiosis
6%
Prevalence
5%
Mitogen Activated Protein Kinase
5%
Phosphatidylinositol 3 Kinase
5%
S6 Kinase
5%
12-O-Tetradecanoylphorbol-13-Acetate
5%
Medicine and Dentistry
Osteoporosis
100%
Maturity Onset Diabetes of the Young
41%
Cardiovascular System
31%
Chronic Kidney Disease
23%
Incretin
19%
Randomized Controlled Trial
19%
Intensive Care
19%
Primary Hyperaldosteronism
19%
Phosphate Transporter
19%
Aortic Smooth Muscle Cell
19%
Cardiopulmonary Resuscitation
19%
Urinary System
19%
Atrial Fibrillation
19%
Lifestyle Disease
19%
Protein Z
19%
ECG Abnormality
19%
Surgical Staple
19%
Subclinical Hypothyroidism
19%
Cardiac Marker
19%
Hemoglobin A1c
13%
Group Therapy
13%
Thiazolidinedione
13%
Transcription Factor Pit 1
11%
Blood Pressure
11%
Hazard Ratio
11%
Fragility Fracture
10%
Bone Fragility
10%
Aminoacidemia
9%
Type 2 Diabetes
9%
Carbohydrate Analysis
9%
FRAX
8%
Group Therapy
8%
Patient with Type 2 Diabetes
8%
Low Density Lipoprotein Cholesterol
8%
All Cause Mortality
8%
Glomerulus Basement Membrane
7%
Creatinine
7%
Coronary Artery Disease
6%
Hip Fracture
6%
Dyslipidemia
6%
Systolic Blood Pressure
6%
Bone Structure
6%
Metabolic Regulation
6%
Enhancer Region
6%
Carotid Artery Stenting
5%
Carotid Endarterectomy
5%
Coronary Artery Bypass Surgery
5%
Myocardial Infarction
5%
Apoplexy
5%
Transluminal Coronary Angioplasty
5%
Health Care
5%